Last reviewed · How we verify
umbilical cord blood mononuclear cells
umbilical cord blood mononuclear cells is a Biologic drug developed by Shandong Qilu Stem Cells Engineering Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | umbilical cord blood mononuclear cells |
|---|---|
| Sponsor | Shandong Qilu Stem Cells Engineering Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study (PHASE1, PHASE2)
- Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple Sclerosis (PHASE1)
- A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation. (PHASE1)
- Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease (EARLY_PHASE1)
- Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury (EARLY_PHASE1)
- Study on Safety and Efficacy of UCB-MNCs for Chronic Radiation Enteritis (EARLY_PHASE1)
- UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients (PHASE1)
- Phase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte in the Acute Ischemic Stroke (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- umbilical cord blood mononuclear cells CI brief — competitive landscape report
- umbilical cord blood mononuclear cells updates RSS · CI watch RSS
- Shandong Qilu Stem Cells Engineering Co., Ltd. portfolio CI
Frequently asked questions about umbilical cord blood mononuclear cells
What is umbilical cord blood mononuclear cells?
umbilical cord blood mononuclear cells is a Biologic drug developed by Shandong Qilu Stem Cells Engineering Co., Ltd..
Who makes umbilical cord blood mononuclear cells?
umbilical cord blood mononuclear cells is developed by Shandong Qilu Stem Cells Engineering Co., Ltd. (see full Shandong Qilu Stem Cells Engineering Co., Ltd. pipeline at /company/shandong-qilu-stem-cells-engineering-co-ltd).
What development phase is umbilical cord blood mononuclear cells in?
umbilical cord blood mononuclear cells is in Phase 1.